The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price gain of 70.76% this year. Over the last six months, there has been a weaker performance of 19.68%. The price of POAI fallen by 79.54% during the last 30 days period. For the last 5-days stocks have improved 4.49%.
Predictive Oncology Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $3.76 on 02/22/24, while the lowest price for the same period was registered at $0.55 on 10/15/24.
52-week price history of POAI Stock
Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Predictive Oncology Inc’s current trading price is -62.76% away from its 52-week high, while its distance from the 52-week low is 154.58%. The stock’s price range during this time has been between $0.55 and $3.76. The trading volume for the Healthcare sector company’s shares reached about 1.26 million for the day, which was higher than the average daily volume of 1.13 million over the last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Predictive Oncology Inc (POAI) has experienced a quarterly rise of 154.54% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.33M and boasts a workforce of 34 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.8339, with a change in price of +0.4300. Similarly, Predictive Oncology Inc recorded 750,536 in trading volume during the last 100 days, posting a change of +45.26%.
POAI’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for POAI stands at 1.22. Similarly, the long-term debt-to-equity ratio is also 0.86.
POAI Stock Stochastic Average
Today, Predictive Oncology Inc’s raw stochastic average for the past 50 days stands at 31.29%, indicating a rise from the raw stochastic average of the last 20 days, which was 30.00%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 24.86% and 24.72% respectively.
